Aviva Systems Biology, founded in 2002, is a leading player in the biotechnology industry. With the slogan "We have your target covered!", the company specializes in providing polyclonal and monoclonal antibodies, ELISA kits, proteins, and custom services for research needs. Based in San Diego, CA, with another office in Beijing, China, Aviva offers a wide range of products and services to assist researchers with various proteomic objectives.
The company's offerings include 24,000 validated polyclonal antibodies and nearly 20,000 ELISA kits. Additionally, Aviva provides custom laboratory services such as protein expression and purification, antibody development, and ELISA development, validation, and production.
Aviva stands out with its unique focus on research associated with 10,000 unique species, 10,000 cellular processes, and 5,000 protein pathways, catering to a wide range of research areas including transcription factors, cancer, cardiovascular, cell biology, DNA damage and repair, epigenetics, signal transduction, cell differentiation, and stem cell biology, among others.
The company's specialties cover areas such as western blot, immunohistochemistry, ELISA, and custom protein expression. The innovative products and services offered by Aviva Systems Biology make it a key player in the biotechnology space, showcasing potential for growth and market impact.
There is no investment information
No recent news or press coverage available for Aviva Systems Biology.